Skip to main content
. 2019 May 21;10:1111. doi: 10.3389/fimmu.2019.01111

Figure 6.

Figure 6

CD16+ monocytes exhibit a prevalence of target mRNAs involved in atherosclerosis. (A) Number of altered microRNAs in CD14+ and CD16+ RA monocytes compared to HDs. 31 were specifically regulated in CD14+ RA monocytes, 153 were specifically regulated in CD16+ RA monocytes and 20 microRNAs were commonly altered in both subtypes in RA patients compared to HDs. (B) Among all the altered microRNAs in CD14+ and CD16+ RA monocytes, number of microRNAs involved in atherosclerosis pathway according to IPA. (C) Putative mRNA targets of the microRNAs altered in CD14+ RA monocytes compared to CD14+ HD monocytes involved in atherosclerosis according to IPA. (D) Putative mRNA targets of the microRNAs altered in CD16+ RA monocytes compared to CD16+ HD monocytes involved in atherosclerosis according to IPA.